Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Paliperidone 3 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paliperidone 6 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paliperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paliperidone palmitate |
Is a |
False |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paliperidone palmitate |
Is modification of (attribute) |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only paliperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone 6 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone 6 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone 3 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone 3 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only paliperidone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone (as paliperidone palmitate) 200 mg/mL prolonged-release suspension for injection |
Has basis of strength substance (attribute) |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paliperidone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
9-Hydroxyrisperidone measurement |
Component |
True |
Paliperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |